Join the club for FREE to access the whole archive and other member benefits.

Phil Taylor

Author at Pharmaphorum

Phil Taylor is currently working as author at pharmaphorum.

Visit website: https://pharmaphorum.com/author/phil-taylor/

See also

pharmaphorum

Leading online destination for healthcare and pharmaceutical industry news

Details last updated 10-Dec-2020

Articles written by Phil Taylor

Neuralink advances brain implant to control robotic arm

Neuralink advances brain implant to control robotic arm

pharmaphorum - 28-Nov-2024

Paving the way for greater independence in patients with paralysis

RYSE invests $50 million in digital diagnostics startup

RYSE invests $50 million in digital diagnostics startup

pharmaphorum - 05-Mar-2024

Braingaze to develop apps for ADHD, autism and alzheimer's using eye-tracking technology

Smartphones are soon to be upgraded as a skin cancer diagnostic tool in UK

Smartphones are soon to be upgraded as a skin cancer diagnostic tool in UK

pharmaphorum - 29-Apr-2022

AI based-DERM could speed up diagnosis by replacing dermatology appointments

23andMe acquired virtual healthcare firm Lemonaid Health for $400M

23andMe acquired virtual healthcare firm Lemonaid Health for $400M

pharmaphorum - 25-Oct-2021

Merger to improve remote health services and offer personalised treatment plans

FDA warns robotic surgery for breast cancer is unproven and could pose health risks

FDA warns robotic surgery for breast cancer is unproven and could pose health risks

pharmaphorum - 22-Aug-2021

Prior study approval and monitoring long-term outcomes are needed to ensure patient's safety

Clinical experience in artificial heart with autoregulation of blood flow

Clinical experience in artificial heart with autoregulation of blood flow

pharmaphorum - 15-Jul-2021

New heart replacement therapy for patients with end-stage biventricular failure

New CRISPR gene-editing drug for a rare protein-misfolding disorder

New CRISPR gene-editing drug for a rare protein-misfolding disorder

pharmaphorum - 28-Jun-2021

Phase 1 trial reports, single dose of the drug cuts protein levels by 87% in ATTR amyloidosis

Microsoft AI tool fastens cancer screening tests in hospitals

Microsoft AI tool fastens cancer screening tests in hospitals

pharmaphorum - 09-Dec-2020

Project InnerEye reduces clinicians workload and improves cancer care